CLL Society wants to hear from you. Part of our organization’s mission is to increase patient education and research. We need your support to increase the body of knowledge for patients and caregivers affected by CLL. Please see current surveys below that help us aggregate information on a variety of topics to inform our field and CLL Society, so we can better serve this community.
How much do you know about the critical tests which can predict which patients will do well on or fail certain medications? Prognostic testing should be done before each and every treatment decision; share your experience and test your knowledge by completing the Test Before Treat Survey!
CAR-T (Chimeric Antigen Receptor-T cell) therapy is an exciting cellular immunotherapy with the potential to treat many cancers including chronic lymphocytic leukemia (CLL) and lymphomas. Please take a moment to complete our very brief, reader survey covering CAR-T Therapy. We will share the results in our March 2020 CLL Society Tribune.
Please take a few moments to let us know about your experience with the CLL Society Patient & Caregiver Support Group. Your feedback will allow us to demonstrate the value and impact of these groups, and call attention to ways in which we can improve the experience for you and other members of the CLL community. Thank you in advance for your time.